NASDAQ NMS - GLOBAL MARKET · OCUL
-1.10% · -$0.1100 · Vol 954.6K
Live · updated 14:22:40 ET
Ocular Therapeutix Inc

Ocular Therapeutix Inc

Pharmaceuticals
$9.88
Card
Relationship Map

Follow $OCUL

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $OCUL by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
OCUL
Ocular Therapeutix Inc
Sat Sep 19 · completed session · daily score · 2d old
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

56/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Sat Sep 19 · completed session · daily score · 2d old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OCUL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OCUL catalysts
About Ocular Therapeutix Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
325
Country
US

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$10.08
Day high
$10.17
Day low
$9.81
Previous close
$9.99
52W high
$16.11
-38.67% from high
52W low
$6.88
33% of range
Market cap
$2.2B
EPS
$-1.5200
Beta
0.72
Shares out
219.6M
Volume
954.6K
0.36× rel vol
Avg volume
2.7M
VWAP
$9.94
Price history computed in-house
1W
-7.84%
1M
-10.83%
3M
-2.32%
1Y
-18.35%
YTD
-18.62%
SMA 50 $9.87 · above
SMA 200 $9.88 · below
52W position 33%

OCUL overview

Veridion Score
56
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OCUL.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OCUL Form 4 filings
Public disclosures

Congress activity in OCUL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OCUL in the cached public ledger.

Federal contracts

OCUL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OCUL in this window.
Lobbying spend

OCUL lobbying filings, year to date.

Registered lobbying filings matched to Ocular Therapeutix Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OCUL in this window.
Loading news for OCUL
Analyst ratings
Sovereign unlock shows live analyst consensus for OCUL.
Options
Sovereign unlock shows live options positioning for OCUL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.